000			01497na a2200253 4500
003			H12O
005			20180417112608.0
008			130622s2011 xxx||||| |||| 00| 0 eng d
040			_cH12O
041			_aeng
100			_aBenito León, Julián _9892 _eNeurología
100			_9582 _aBermejo Pareja, Félix _eNeurología
100			_aGuijarro Castro, Cristina _91774 _eNeurología
245	0	0	_aWidespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis _h[artículo]
260			_bNeurological Sciences, _c2011
300			_a32(2):309-311.
500			_aFormato Vancouver: Guijarro C, Benito-León J, Bermejo-Pareja F. Widespread urticaria due to intramuscular interferon beta-1a therapy for multiple sclerosis. Neurol Sci. 2011 Apr;32(2):309-11.
501			_aPMID:20890624
504			_aContiene 9 referencias
520			_aWe describe two multiple sclerosis patients who displayed widespread urticaria due to intramuscular interferon beta-1a (INF-beta-1a). Clinicians should be aware of this adverse event, since it may be severe and it may lead to the definitive interruption of treatment. Widespread urticaria complicating intramuscular INF-beta-1a therapy in multiple sclerosis should be therefore added to the list of dermatological lesions associated with interferon therapy.
710			_9267 _aServicio de Neurología-Neurofisiología
856			_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/5/pc5763.pdf _ySolicitar documento
942			_n0 _2ddc _cART
999			_c5763 _d5763